| Item | Cat. No. | Type | Clone No |
| Anti-SARS-CoV-2 Spike RBD mAbs [Plutavimab Biosimilar] (MABL-5109) | MABL-5109 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Zaire Ebolavirus Glycoprotein mAbs [Porgaviximab Biosimilar] (MABL-5110) | MABL-5110 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Pradusinstobart Biosimilar] (MABL-5111) | MABL-5111 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-ACVR1 mAbs [Prafnosbart Biosimilar] (MABL-5112) | MABL-5112 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ALCAM/CD166 mAbs [Praluzatamab Biosimilar] (MABL-5113) | MABL-5113 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-SNCA/PARK1/PARK4 mAbs [Prasinezumab Biosimilar] (MABL-5114) | MABL-5114 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CEACAM5/CD66e mAbs [Precemtabart Biosimilar] (MABL-5115) | MABL-5115 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-ICOSLG mAbs [Prezalumab Biosimilar] (MABL-5116) | MABL-5116 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-Shiga Toxin Type 1 mAbs [Pritoxaximab Biosimilar] (MABL-5117) | MABL-5117 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VIM mAbs [Pritumumab Biosimilar] (MABL-5118) | MABL-5118 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TBC mAbs [Produvofusp Biosimilar] (MABL-5119) | MABL-5119 | ELISA, FACS, Functional assay, in vivo binding | na, na |
| Anti-PDCD1/CD279/PD1 mAbs [Prolgolimab Biosimilar] (MABL-5120) | MABL-5120 | ELISA, FACS, Functional assay, in vivo binding | G1, Lambda |
| Anti-PDCD1/CD279/PD1 mAbs [Pucotenlimab Biosimilar] (MABL-5121) | MABL-5121 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-KDR/CD309/VEGFR2 mAbs [Pulocimab Biosimilar] (MABL-5122) | MABL-5122 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VEGFA mAbs [Pumitamig1 Biosimilar] (MABL-5123) | MABL-5123 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDL1/CD274 mAbs [Pumitamig2 Biosimilar] (MABL-5124) | MABL-5124 | ELISA, FACS, Functional assay, in vivo binding | na, na |
| Anti-MS4A1/CD20;CD3E mAbs [Plamotamab Biosimilar] (MABL-5095) | MABL-5095 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Kappa |
| Anti-CSF2 mAbs [Plonmarlimab Biosimilar] (MABL-5096) | MABL-5096 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CCR2/CD192 mAbs [Plozalizumab Biosimilar] (MABL-5097) | MABL-5097 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF17/BCM/BCMA/CD269/TNFRSF13A;ALB mAbs [Podentamig1 Biosimilar] (MABL-5098) | MABL-5098 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
